日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial

奥拉帕尼、度伐利尤单抗和环磷酰胺联合预后血液特征治疗铂敏感卵巢癌:一项随机 II 期 SOLACE2 试验

Chee Khoon Lee ,Apriliana E R Kartikasari # ,Nirashaa T Bound # ,Katherine E Francis ,Kristy Shield-Artin ,Justin Bedo ,Ksenija Nesic ,Katrina Diamante ,Rachel L O'Connell ,Mutsa Madondo ,Momodou Cox ,Claire Davies ,Cyril Deceneux ,Georgia Goodchild ,Andrew Jarratt ,Emily Cassar ,Hina Amer ,U G Imalki U Kariyawasam ,Yeh Chen Lee ,Janine Lombard ,Sally Baron-Hay ,Yoland Antill ,Catherine Shannon ,Sudarshan Selva-Nayagam ,Philip Beale ,Danka Zebic ,Sandy Simon ,Anneliese Linaker ,Michael A Quinn ,Anthony T Papenfuss ,Matthew J Wakefield ,Cassandra J Vandenberg ,Michael Friedlander # ,Clare L Scott # ,Magdalena Plebanski #

Promising Anticancer Activity of [Bis(1,8-quinolato)palladium (II)] Alone and in Combination

[双(1,8-喹啉)钯 (II)] 单独和联合使用均具有良好的抗癌活性

Md Nur Alam, Mohammad Ali Moni, Jun Q Yu, Philip Beale, Peter Turner, Nick Proschogo, Mohammad Azizur Rahman, M Pear Hossain, Fazlul Huq

Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models

顺铂与选定植物化学物质的序列组合可克服卵巢肿瘤模型中的耐药性

Safiah Ibrahim Althurwi, Jun Q Yu, Philip Beale, Fazlul Huq

Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models

卡铂和奥沙利铂与硼替佐米序贯联合用于卵巢肿瘤模型

Zaynab Al-Eisawi, Philip Beale, Charles Chan, Jun Q Yu, Fazlul Huq

Identification of distinctive protein expression patterns in colorectal adenoma

鉴定结直肠腺瘤中独特的蛋白质表达模式

Francis F Lam, Lucy Jankova, Owen F Dent, Mark P Molloy, Sun Young Kwun, Candice Clarke, Pierre Chapuis, Graham Robertson, Philip Beale, Stephen Clarke, E Les Bokey, Charles Chan